SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
Background: The B-FAST project of the National University Network (NUM) examines and records applied surveillance strategies implemented in hospitals i.a., to protect patients and employees from infection.Methods: Infection control physicians in German university hospitals (UK), as well as non-univ...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | DE EN |
Publicado: |
German Medical Science GMS Publishing House
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6366d2de894543d0893b1e05f52a5b0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6366d2de894543d0893b1e05f52a5b0d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6366d2de894543d0893b1e05f52a5b0d2021-11-25T07:15:31ZSARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST2196-522610.3205/dgkh000402https://doaj.org/article/6366d2de894543d0893b1e05f52a5b0d2021-11-01T00:00:00Zhttp://www.egms.de/static/en/journals/dgkh/2021-16/dgkh000402.shtmlhttps://doaj.org/toc/2196-5226Background: The B-FAST project of the National University Network (NUM) examines and records applied surveillance strategies implemented in hospitals i.a., to protect patients and employees from infection.Methods: Infection control physicians in German university hospitals (UK), as well as non-university hospitals (NUK; Bavaria, Lower Saxony) were surveyed in March 2021 regarding SARS-CoV-2 testing/surveillance strategies in a cross-sectional study using a standardized online questionnaire. The focus was on screening strategies taking into account the “test” methods used (case history, PCR, antigen, antibody test).Results: The response rate was 91.7% (33/36) in UK and 11.3%–32.2% in NUK. Almost all hospitals (95.0%) performed a symptom and exposure check and/or testing upon inpatient admission. Non-cause-related testing (screening) of health care workers in COVID wards was preferably done by PCR in UK (69.7% PCR; 12.1% antigen), while NUK (29.9% PCR; 49.3% antigen) used antigen testing more frequently. Regardless of the type of facility, about half of the respondents rated the benefit of screening higher than the effort (patients: 49%; employees: 45%).Conclusion: Testing/surveillance strategies find a high level of acceptance at German hospitals and are generally carried out in accordance with the national testing strategy with differences depending on the level of care.Heinemann, StephanieBludau, AnnaKaba, HaniKnolle, PercyGrundmann, HajoScheithauer, SimoneGerman Medical Science GMS Publishing Housearticlehospitalsars-cov-2screeningsurveillanceuniversity hospitalMedicineRPublic aspects of medicineRA1-1270MicrobiologyQR1-502DEENGMS Hygiene and Infection Control, Vol 16, p Doc31 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
DE EN |
topic |
hospital sars-cov-2 screening surveillance university hospital Medicine R Public aspects of medicine RA1-1270 Microbiology QR1-502 |
spellingShingle |
hospital sars-cov-2 screening surveillance university hospital Medicine R Public aspects of medicine RA1-1270 Microbiology QR1-502 Heinemann, Stephanie Bludau, Anna Kaba, Hani Knolle, Percy Grundmann, Hajo Scheithauer, Simone SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST |
description |
Background: The B-FAST project of the National University Network (NUM) examines and records applied surveillance strategies implemented in hospitals i.a., to protect patients and employees from infection.Methods: Infection control physicians in German university hospitals (UK), as well as non-university hospitals (NUK; Bavaria, Lower Saxony) were surveyed in March 2021 regarding SARS-CoV-2 testing/surveillance strategies in a cross-sectional study using a standardized online questionnaire. The focus was on screening strategies taking into account the “test” methods used (case history, PCR, antigen, antibody test).Results: The response rate was 91.7% (33/36) in UK and 11.3%–32.2% in NUK. Almost all hospitals (95.0%) performed a symptom and exposure check and/or testing upon inpatient admission. Non-cause-related testing (screening) of health care workers in COVID wards was preferably done by PCR in UK (69.7% PCR; 12.1% antigen), while NUK (29.9% PCR; 49.3% antigen) used antigen testing more frequently. Regardless of the type of facility, about half of the respondents rated the benefit of screening higher than the effort (patients: 49%; employees: 45%).Conclusion: Testing/surveillance strategies find a high level of acceptance at German hospitals and are generally carried out in accordance with the national testing strategy with differences depending on the level of care. |
format |
article |
author |
Heinemann, Stephanie Bludau, Anna Kaba, Hani Knolle, Percy Grundmann, Hajo Scheithauer, Simone |
author_facet |
Heinemann, Stephanie Bludau, Anna Kaba, Hani Knolle, Percy Grundmann, Hajo Scheithauer, Simone |
author_sort |
Heinemann, Stephanie |
title |
SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST |
title_short |
SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST |
title_full |
SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST |
title_fullStr |
SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST |
title_full_unstemmed |
SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST |
title_sort |
sars-cov-2 surveillance and testing: results of a survey from the network of university hospitals (num), b-fast |
publisher |
German Medical Science GMS Publishing House |
publishDate |
2021 |
url |
https://doaj.org/article/6366d2de894543d0893b1e05f52a5b0d |
work_keys_str_mv |
AT heinemannstephanie sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast AT bludauanna sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast AT kabahani sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast AT knollepercy sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast AT grundmannhajo sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast AT scheithauersimone sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast |
_version_ |
1718413622045048832 |